Framing Angle (from Research)
Eniola's CCT model (computational neuropharmacology, reward-memory encoding, Bayesian MCMC validation) would map naturally onto the Molecular Medicine track, and her profile is scientifically compelling. However, the programme cannot be applied to: her background, skills, preprints, or independent research would not change the eligibility calculus — the submission itself must be an essay based on completed PhD thesis work, accompanied by a PhD certificate and thesis committee reference letter, and her highest degree is a B.Pharm (2021). If she is admitted to and completes an MSc at MUG/Graz with a strong thesis, she should watch for the 2028 or 2029 cycle (the PhD window shifts annually, so the relevant year will depend on when she receives her doctorate).
Full Research →
The full draft is saved at .
Here is what was written and what you must know before touching the submit button.
WHAT IS IN THE DRAFT
PRIZE ESSAY (~820 words, Molecular Medicine track). The essay opens with the synaptic mechanism, introduces the CCT architecture, walks through the ODE/RK45 calibration, the PyMC MCMC inference (4,000 posterior samples, R-hat < 1.01), and the five pre-registered hypotheses H1-H5. It reports the specific numbers: encoding probability 0.855 to 0.122 (85.8% reduction), super-additivity +12.8 pp (95% CrI: +9.3 to +16.4 pp). It then extends to IMPRINT, the TOPOLOGIX hERG screening logic, and the generalisation argument to PTSD and Alzheimer's disease via the shared NMDA-consolidation circuit. Fifteen numbered references are provided; eight are marked as placeholders you must replace with the exact published sources you used to parameterise the ODE system.
LIST OF PUBLICATIONS, AWARDS, AND EXPERIENCE. All three CCT preprints are cited with DOIs. The co-authored Alcohol paper and the Neuroscience and Biobehavioral Reviews submission are noted as under review with instructions to insert full citations if accepted before the 15 July 2026 deadline.
CHECKLIST. Fourteen action items, including account creation, the reference letter, the thesis abstract upload, and the AI-use declaration.
THE HARD STOP YOU MUST READ
The 2026 prize requires a PhD awarded between 1 January 2024 and 31 December 2025. You hold a B.Pharm. You are ineligible for this cycle. The reference letter requirement (from a thesis advisor or thesis committee member) and the thesis abstract requirement (up to four double-spaced pages of the doctoral thesis) cannot be fulfilled without a completed doctorate. Submitting with these documents absent or falsified would result in immediate disqualification and could damage your reputation with Science/AAAS editors.
This draft is your preparation document. It will be in excellent shape for the 2029 or 2030 cycle, depending on when your doctorate is conferred. Save it. The CCT argument maps cleanly onto Molecular Medicine, and the Bayesian MCMC framing is exactly what Science editors in this track respond to.